Pulmonary Function Tests in the Evaluation of Early Lung Disease in Cystic Fibrosis

Katarzyna Walicka-Serzysko1,2, Magdalena Postek1,2, Urszula Borawska-Kowalczyk1,2

  • 1Cystic Fibrosis Department, Institute of Mother and Child, 01-211 Warsaw, Poland.

PubMed

Insights

Multiple breath nitrogen washout (MBNW) and impulse oscillometry (IOS) are superior to spirometry for detecting early lung disease in children with cystic fibrosis (CF). The lung clearance index (LCI) is a more sensitive measure than FEV1.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Cystic Fibrosis Research

Background:

  • Early detection of respiratory dysfunction is critical in pediatric cystic fibrosis (CF) management.
  • Conventional pulmonary function tests (PFTs) may not adequately capture early lung disease in CF.
  • Novel techniques are needed to assess subtle changes in lung function.

Purpose of the Study:

  • To evaluate the effectiveness of multiple breath nitrogen washout (MBNW) and impulse oscillometry (IOS) in assessing early lung disease in children with CF.
  • To compare MBNW and IOS with conventional spirometry and body plethysmography.
  • To identify sensitive biomarkers for early functional abnormalities.

Main Methods:

  • Prospective study involving 69 children with CF aged 7-18 years.
  • Pulmonary function tests including MBNW, IOS, spirometry, and body plethysmography were performed.
  • Nutritional status, microbiological data, pulmonary exacerbations (PExs), and health-related quality of life (HRQoL) were also assessed.

Main Results:

  • Spirometry showed normal lung function in 49.3%, mild disease in 36.2%, and moderate disease in 14.5% of patients.
  • An elevated lung clearance index (LCI > 6.98), a measure from MBNW, was found in 85% of children with normal spirometry (FEV1 ≥ 90%pred).
  • Pseudomonas aeruginosa infection and a higher number of PExs correlated with poorer PFT results.

Conclusions:

  • MBNW and IOS are more sensitive than conventional techniques for evaluating early lung disease in pediatric CF.
  • The lung clearance index (LCI) is a more effective parameter than forced expiratory volume in 1 second (FEV1) for detecting functional abnormalities in school-aged children with CF.
Abstract

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
371
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
289
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
194